Generali Investments CEE investicni spolecnost a.s. Purchases New Position in Humana Inc. (NYSE:HUM)

Generali Investments CEE investicni spolecnost a.s. purchased a new stake in Humana Inc. (NYSE:HUM) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 500 shares of the insurance provider’s stock, valued at approximately $127,000.

A number of other institutional investors have also recently made changes to their positions in the business. Bank Julius Baer & Co. Ltd Zurich bought a new position in shares of Humana in the 4th quarter valued at about $86,000. AMG National Trust Bank purchased a new position in shares of Humana during the fourth quarter valued at approximately $1,510,000. Edgestream Partners L.P. boosted its position in shares of Humana by 372.1% during the fourth quarter. Edgestream Partners L.P. now owns 13,515 shares of the insurance provider’s stock valued at $3,429,000 after buying an additional 10,652 shares during the period. Prescott Group Capital Management L.L.C. boosted its position in shares of Humana by 100.0% during the fourth quarter. Prescott Group Capital Management L.L.C. now owns 11,464 shares of the insurance provider’s stock valued at $2,909,000 after buying an additional 5,732 shares during the period. Finally, BBR Partners LLC purchased a new position in shares of Humana during the fourth quarter valued at approximately $5,393,000. Institutional investors own 92.38% of the company’s stock.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.32% of the stock is owned by insiders.

Humana Stock Performance

Shares of HUM stock opened at $259.86 on Monday. The business’s fifty day simple moving average is $271.80 and its 200-day simple moving average is $283.10. The company has a market cap of $31.35 billion, a PE ratio of 26.12, a PEG ratio of 2.05 and a beta of 0.57. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.36%. The ex-dividend date is Friday, March 28th. Humana’s payout ratio is 35.58%.

Analyst Ratings Changes

HUM has been the subject of several recent analyst reports. JPMorgan Chase & Co. dropped their target price on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a research report on Tuesday, February 18th. Piper Sandler boosted their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Morgan Stanley dropped their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. Finally, StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Twenty equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $285.68.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.